Thank you for joining us at our #EHA2024 Satellite Symposium to discuss novel treatment strategies for resolving unmet needs on immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA). Missed the presentation? Available on demand until August 15th, 2024. https://lnkd.in/dWZZErQh #Novartis #Hematology
About us
Committed to providing medical & scientific disease education to healthcare professionals globally. See our community guidelines: https://bit.ly/3PAq2J7 If you have a medical inquiry, please contact your local Novartis Medical contact via https://www.novartis.com/healthcare-professionals/novartis-medical-information. Our posts are for healthcare professionals only. • Please be patient; sometimes responses take time. • Please do not include your personal information in your posts. • We will respond to your questions/comments M-F, 9a-5p CET (no holidays). • The purpose of our posts is to share disease state education, medical information and scientific data, and congress updates. We reserve the right to hide or remove any post that mentions specific product(s) or treatment(s) as that is not the intent of our posts. • If needed, we’ll show you how to get us your contact and case info securely. • We reserve the right to engage with posts on a case-by-case basis; not all posts will be acknowledged or responded to. • Novartis Innovative Medicines does not endorse and is not responsible for the content of third-party links we may share. • Replying to or mentioning users does not imply our endorsement. For US healthcare professionals, please check our dedicated page: Novartis US Medical: https://www.linkedin.com/showcase/novartis-us-medical/
- Website
-
https://www.novartis.com/
External link for Novartis Medical
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
Updates
-
At Novartis, our long-standing commitment to patients living with chronic myeloid leukemia (CML) spans more than two decades, marked by breakthroughs that have helped turn what was once a life-limiting condition into a chronic one for many. Yet, there's more ground to cover. Despite advancements, many patients still face hurdles such as lower response rates, treatment resistance, and intolerance, and have poor quality of life. That’s why we’re committed to continuing to pioneer targeted treatments for CML, and ensuring every patient has access to innovative medicines. Learn more here: https://lnkd.in/daK2pMbM
-
The Novartis #paroxysmalnocturnalhemoglobinuria symposium is now available on demand! Join us on the #EHA2024 Congress platform where the session will be available until 15 August. https://lnkd.in/dDnHp8kw
-
-
Thank you for joining us at #EHA2024 to learn more about our commitment to improve the quality of life of CML patients! If you missed our #CML Satellite Symposium, now is available on demand until August 15th, 2024👇 https://lnkd.in/d-fNgwJr #Novartis #Hematology
-
-
Don't miss the highlights of our days in #EHA2024 congress with Jonathan van Garsse, International Disease Area Head Hematology, and discover how #Novartis is dedicated to transform the treatment of blood cancers and serious blood disorders. Follow along to stay up to date on the latest from Novartis!
-
Thank you to all healthcare professionals who joined us at #EHA2024 for our Satellite Symposium on managing high-risk Polycythemia Vera 👏 Missed the presentation? You can watch it on-demand until 15 August. https://lnkd.in/d3BThGC4 #Novartis #Hematology
-
Watch Jeff Legos, Executive Vice President, Global Head of Oncology Development, highlight our long-standing commitment to #reimaginemedicine for patients living with cancer and blood disorders at #EHA2024. Stay tuned to learn more about Novartis journey!
-
Thank you for joining us at #EHA2024! 🩺 #Novartis #Hematology
-
Take a sneak peek behind the scenes! Our #Novartis booth at #EHA2024 in Madrid is coming together. Join us from June 13th to 16th to explore how Novartis is reimagining cancer and blood disorders. https://lnkd.in/dnGpQssa